16 August 2022: Original Paper
Evaluation of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program in Comparison to Standard Allocation
Nelly Delaly Eklou 1BCDE , Bernd M. Jänigen 2E , Przemylsaw Pisarski 2E , Gerd Walz 1E , Johanna Schneider 1ABCDEF*DOI: 10.12659/AOT.936514
Ann Transplant 2022; 27:e936514
Table 3 Graft function and mortality.
| Parameter | ESP n=116 | ETKAS n=111 | p-value |
|---|---|---|---|
| Overall mortality, n (%) | 52 (44.8) | 15 (13.5) | * |
| Cause of death | |||
| Infectious disease, n (%) | 20 (17.2) | 9 (8.1) | * |
| Cardiovascular event, n (%) | 6 (5.2) | 0 (0.0) | * |
| Thromboembolic event, n (%) | 4 (3.4) | 2 (1.8) | 0.684 |
| Cancer, n (%) | 5 (4.3) | 0 (0.0) | 0.060 |
| Unknown, n (%) | 17 (14.7) | 4 (3.6) | * |
| Duration between transplantation and death (months) | 40.5±4.6 | 21.4±6.0 | * |
| Death with functioning graft, n (%) | 24 (20.7) | 4 (3.6) | * |
| Data are presented as mean±standard error of the mean (SEM) unless otherwise indicated. ESP – Eurotransplant Senior Program; ETKAS – Eurotransplant Transplant Kidney Allocation System. * | |||